Barclays Maintains Overweight on MetLife, Raises Price Target to $93

Benzinga Newsdesk www.benzinga.com Positive 73.2%

Neg 0% Neu 0% Pos 73.2%

Barclays analyst Alex Scott maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $89 to $93.

Comments

No comments yet. Be the first!